These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The functions of UCH-L1 and its relation to neurodegenerative diseases. Setsuie R; Wada K Neurochem Int; 2007; 51(2-4):105-11. PubMed ID: 17586089 [TBL] [Abstract][Full Text] [Related]
5. Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. Choi J; Sullards MC; Olzmann JA; Rees HD; Weintraub ST; Bostwick DE; Gearing M; Levey AI; Chin LS; Li L J Biol Chem; 2006 Apr; 281(16):10816-24. PubMed ID: 16517609 [TBL] [Abstract][Full Text] [Related]
6. Backbone and side-chain 1H, 15N and 13C resonance assignments of S18Y mutant of ubiquitin carboxy-terminal hydrolase L1. Tse HS; Hu HY; Sze KH Biomol NMR Assign; 2011 Oct; 5(2):165-8. PubMed ID: 21298373 [TBL] [Abstract][Full Text] [Related]
7. Familial Mutations and Post-translational Modifications of UCH-L1 in Parkinson's Disease and Neurodegenerative Disorders. Lee YC; Hsu SD Curr Protein Pept Sci; 2017; 18(7):733-745. PubMed ID: 26899237 [TBL] [Abstract][Full Text] [Related]
8. Insights into links between familial and sporadic Parkinson's disease: physical relationship between UCH-L1 variants and chaperone-mediated autophagy. Kabuta T; Wada K Autophagy; 2008 Aug; 4(6):827-9. PubMed ID: 18635949 [TBL] [Abstract][Full Text] [Related]
9. Mass spectrometry assessment of ubiquitin carboxyl-terminal hydrolase L1 partitioning between soluble and particulate brain homogenate fractions. Chen J; Huang RY; Turko IV Anal Chem; 2013 Jun; 85(12):6011-7. PubMed ID: 23682718 [TBL] [Abstract][Full Text] [Related]
10. Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants. Nishikawa K; Li H; Kawamura R; Osaka H; Wang YL; Hara Y; Hirokawa T; Manago Y; Amano T; Noda M; Aoki S; Wada K Biochem Biophys Res Commun; 2003 Apr; 304(1):176-83. PubMed ID: 12705903 [TBL] [Abstract][Full Text] [Related]
11. Cyclopentenone prostaglandin-induced unfolding and aggregation of the Parkinson disease-associated UCH-L1. Koharudin LM; Liu H; Di Maio R; Kodali RB; Graham SH; Gronenborn AM Proc Natl Acad Sci U S A; 2010 Apr; 107(15):6835-40. PubMed ID: 20231490 [TBL] [Abstract][Full Text] [Related]
12. Oxidative modifications and aggregation of Cu,Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases. Choi J; Rees HD; Weintraub ST; Levey AI; Chin LS; Li L J Biol Chem; 2005 Mar; 280(12):11648-55. PubMed ID: 15659387 [TBL] [Abstract][Full Text] [Related]
13. Cloning and expression analysis of a Parkinson's disease gene, uch-L1, and its promoter in zebrafish. Son OL; Kim HT; Ji MH; Yoo KW; Rhee M; Kim CH Biochem Biophys Res Commun; 2003 Dec; 312(3):601-7. PubMed ID: 14680807 [TBL] [Abstract][Full Text] [Related]
14. Proteomic Analysis of Hippocampus in a Mouse Model of Depression Reveals Neuroprotective Function of Ubiquitin C-terminal Hydrolase L1 (UCH-L1) via Stress-induced Cysteine Oxidative Modifications. Choi JE; Lee JJ; Kang W; Kim HJ; Cho JH; Han PL; Lee KJ Mol Cell Proteomics; 2018 Sep; 17(9):1803-1823. PubMed ID: 29959188 [TBL] [Abstract][Full Text] [Related]
15. Parkin-mediated K63-polyubiquitination targets ubiquitin C-terminal hydrolase L1 for degradation by the autophagy-lysosome system. McKeon JE; Sha D; Li L; Chin LS Cell Mol Life Sci; 2015 May; 72(9):1811-24. PubMed ID: 25403879 [TBL] [Abstract][Full Text] [Related]
16. Parkinson's disease-associated mutations in α-synuclein and UCH-L1 inhibit the unconventional secretion of UCH-L1. Konya C; Hatanaka Y; Fujiwara Y; Uchida K; Nagai Y; Wada K; Kabuta T Neurochem Int; 2011 Aug; 59(2):251-8. PubMed ID: 21693148 [TBL] [Abstract][Full Text] [Related]
17. Identification of tyrosine nitration in UCH-L1 and GAPDH. Guingab-Cagmat JD; Stevens SM; Ratliff MV; Zhang Z; Gold MS; Anagli J; Wang KK; Kobeissy FH Electrophoresis; 2011 Jun; 32(13):1692-705. PubMed ID: 21706495 [TBL] [Abstract][Full Text] [Related]
18. Selective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system. Xilouri M; Kyratzi E; Pitychoutis PM; Papadopoulou-Daifoti Z; Perier C; Vila M; Maniati M; Ulusoy A; Kirik D; Park DS; Wada K; Stefanis L Hum Mol Genet; 2012 Feb; 21(4):874-89. PubMed ID: 22076440 [TBL] [Abstract][Full Text] [Related]
19. N-terminal truncated UCH-L1 prevents Parkinson's disease associated damage. Kim HJ; Kim HJ; Jeong JE; Baek JY; Jeong J; Kim S; Kim YM; Kim Y; Nam JH; Huh SH; Seo J; Jin BK; Lee KJ PLoS One; 2014; 9(6):e99654. PubMed ID: 24959670 [TBL] [Abstract][Full Text] [Related]
20. Genetic association between Ubiquitin Carboxy-terminal Hydrolase-L1 gene S18Y polymorphism and sporadic Alzheimer's disease in a Chinese Han population. Xue S; Jia J Brain Res; 2006 May; 1087(1):28-32. PubMed ID: 16626667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]